Yadanzioside A

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341092

CAS#: 95258-15-4

Description: Yadanzioside A is a biochemical.

Chemical Structure

Yadanzioside A

CAS# 95258-15-4

Handing Instruction

Theoretical Analysis

MedKoo Cat#: 341092
Name: Yadanzioside A
CAS#: 95258-15-4
Chemical Formula: C32H44O16
Exact Mass: 684.2629
Molecular Weight: 684.688
Elemental Analysis: C, 56.14; H, 6.48; O, 37.39

Size	Price	Shipping out time	Quantity
Inquire bulk and customized quantity Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Pricing updated 2021-03-04. Prices are subject to change without notice.

Yadanzioside A is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Synonym: Yadanzioside A

IUPAC/Chemical Name: Yadanzioside A

InChi Key: QDQJWSSPAMZRIA-KEMICICVSA-N

InChi Code: InChI=1S/C32H44O16/c1-11(2)6-17(34)48-23-25-31-10-44-32(25,29(42)43-5)26(40)22(39)24(31)30(4)8-14(18(35)12(3)13(30)7-16(31)47-27(23)41)45-28-21(38)20(37)19(36)15(9-33)46-28/h8,11-13,15-16,19-26,28,33,36-40H,6-7,9-10H2,1-5H3/t12-,13+,15-,16-,19-,20+,21-,22-,23-,24-,25-,26+,28-,30+,31-,32+/m1/s1

SMILES Code: C1(=C[C@@]2([C@H]3[C@H]([C@@H]([C@@]4([C@H]5[C@@]3([C@@H](C[C@H]2[C@@H](C)C1=O)OC([C@@H]5OC(=O)CC(C)C)=O)CO4)C(=O)OC)O)O)C)O[C@H]1[C@@H]([C@@H](O)[C@@H]([C@H](O1)CO)O)O

Appearance:

Solid powder

Purity:

>98% (or refer to the Certificate of Analysis)

Shipping Condition:

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:

Soluble in DMSO

Shelf Life:

>2 years if stored properly

Drug Formulation:

This drug may be formulated in DMSO

Stock Solution Storage:

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:

2934.99.9001

Handling Instructions:

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 684.688 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Reconstitution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Liu JQ, Wang CF, Li XY, Chen JC, Li Y, Qiu MH. One new pregnane glycoside from the seeds of cultivated Brucea javanica. Arch Pharm Res. 2011 Aug;34(8):1297-300. doi: 10.1007/s12272-011-0809-5. Epub 2011 Sep 11. PubMed PMID: 21910051.

2: Zhao M, Lau ST, Leung PS, Che CT, Lin ZX. Seven quassinoids from Fructus Bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines. Phytother Res. 2011 Dec;25(12):1796-800. doi: 10.1002/ptr.3477. Epub 2011 Apr 8. PubMed PMID: 21480411.

3: Yan XH, Chen J, Di YT, Fang X, Dong JH, Sang P, Wang YH, He HP, Zhang ZK, Hao XJ. Anti-tobacco mosaic virus (TMV) Quassinoids from Brucea javanica (L.) Merr. J Agric Food Chem. 2010 Feb 10;58(3):1572-7. doi: 10.1021/jf903434h. PubMed PMID: 20050684.

4: Kim IH, Takashima S, Hitotsuyanagi Y, Hasuda T, Takeya K. New quassinoids, javanicolides C and D and javanicosides B--F, from seeds of Brucea javanica. J Nat Prod. 2004 May;67(5):863-8. PubMed PMID: 15165151.

5: Okuyama E, Gao LH, Yamazaki M. [Studies on pharmacologically active principles from Indonesian crude drugs. III. Toxic components from Brucea javanica (L.) Merr]. Yakugaku Zasshi. 1990 Nov;110(11):834-8. Japanese. PubMed PMID: 2082013.

6: Okano M, Fukamiya N, Toyota T, Tagahara K, Lee KH. Antitumor agents, 104. Isolation of yadanziosides M and P from Brucea antidysenterica and identification of bruceantinoside B as a mixture of yadanzioside P and bruceantinoside C. J Nat Prod. 1989 Mar-Apr;52(2):398-401. PubMed PMID: 2746262.

7: Sakaki T, Yoshimura S, Tsuyuki T, Takahashi T, Honda T. Yadanzioside P, a new antileukemic quassinoid glycoside from Brucea javanica (L.) Merr with the 3-O-(beta-D-glucopyranosyl)bruceantin structure. Chem Pharm Bull (Tokyo). 1986 Oct;34(10):4447-50. PubMed PMID: 3829175.

Your view history